News

Gene therapies are incredibly expensive and tend to benefit small numbers of people, a combination that presents myriad financing challenges for patients, providers, payers and producers. A new study explored some of the options.

Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, shared the results found from his organization's latest report on how many consumers are switching their healthcare providers and insurance payers. In the interview, he touched on some of the main drivers to consumers leaving and solutions on how payer and provider groups can turn things around.